Overview
Mowat-Wilson syndrome (MWS), also known as Mowat-Wilson syndrome due to ZEB2 deficiency or Hirschsprung disease–intellectual disability syndrome, is a rare genetic neurodevelopmental disorder caused by heterozygous loss-of-function mutations or deletions of the ZEB2 (also known as SIP1 or ZFHX1B) gene on chromosome 2q22. The condition affects multiple body systems and is characterized by a distinctive facial appearance (widely spaced eyes, broad nasal bridge, prominent rounded nasal tip, open mouth with M-shaped upper lip, and uplifted earlobes), moderate to severe intellectual disability, delayed motor development, and limited or absent speech. Seizures (epilepsy) occur in the majority of affected individuals, typically presenting in early childhood. Hirschsprung disease (aganglionosis of the colon) is a hallmark feature, present in approximately 50–60% of individuals with MWS, and is often the presenting clinical finding that leads to diagnosis. Other frequently associated anomalies include congenital heart defects (such as patent ductus arteriosus, ventricular septal defect, and pulmonary artery sling), urogenital anomalies (hypospadias, cryptorchidism, renal malformations), eye abnormalities (microphthalmia, coloboma, strabismus), and structural brain anomalies including agenesis or hypoplasia of the corpus callosum. Growth may be affected, with short stature observed in some patients. Individuals with MWS typically have a happy and sociable demeanor. There is no cure for Mowat-Wilson syndrome, and management is supportive and symptom-directed. Hirschsprung disease requires surgical intervention (pull-through procedure). Epilepsy is managed with antiepileptic medications, and congenital heart defects may require surgical correction. Speech therapy, physical therapy, occupational therapy, and special educational support are essential components of long-term care. Regular monitoring by a multidisciplinary team including neurology, cardiology, gastroenterology, urology, and ophthalmology is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Mowat-Wilson syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Mowat-Wilson syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Mowat-Wilson syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Mowat-Wilson syndrome.
Community
No community posts yet. Be the first to share your experience with Mowat-Wilson syndrome.
Start the conversation →Latest news about Mowat-Wilson syndrome
No recent news articles for Mowat-Wilson syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Mowat-Wilson syndrome
What is Mowat-Wilson syndrome?
Mowat-Wilson syndrome (MWS), also known as Mowat-Wilson syndrome due to ZEB2 deficiency or Hirschsprung disease–intellectual disability syndrome, is a rare genetic neurodevelopmental disorder caused by heterozygous loss-of-function mutations or deletions of the ZEB2 (also known as SIP1 or ZFHX1B) gene on chromosome 2q22. The condition affects multiple body systems and is characterized by a distinctive facial appearance (widely spaced eyes, broad nasal bridge, prominent rounded nasal tip, open mouth with M-shaped upper lip, and uplifted earlobes), moderate to severe intellectual disability, del
How is Mowat-Wilson syndrome inherited?
Mowat-Wilson syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Mowat-Wilson syndrome typically begin?
Typical onset of Mowat-Wilson syndrome is neonatal. Age of onset can vary across affected individuals.